Topical Cetirizine 1% vs Minoxidil 5% Gel in Treatment of Androgenetic Alopecia

Launched by ASSIUT UNIVERSITY · Feb 29, 2020

Keywords

ClinConnect Summary

Androgenetic alopecia (AGA), also known as androgenic alopecia or male pattern baldness, is the most common type of progressive hair loss. It is a polygenetic condition with variable degree of severity, age of onset, and location of hair loss.

Hair loss typically begins with bi-temporal recession of the frontal hairline, followed by diffuse hair thinning at the vertex, and eventual complete loss of hair at the center of the vertex. The bald patch at the vertex subsequently joins the frontal receding hairline, leaving an island of hair on the frontal scalp, which finally disappears leaving ...

Gender

MALE

Eligibility criteria

• Inclusion Criteria:
• • 1. Only males with Androgenetic Alopecia.
• • 2. Age (18 - 50) years.
• • 3. AGA grade II to VII according to Norwood-Hamilton classification
• Exclusion Criteria:
• • 1. Females with Androgentic Alopecia.
• • 2. Previous history of sensitivity to Cetirizine.
• • 3. Previous treatment for AGA in the last in the last 3 months
• • 4. Chronic Systemic diseases as; hypotension, cardiac patients, renal failure or liver failure.